Tianjin Zhongxin Pharmaceutical Group Corp Ltd Cash Flow Reinvestment Rate
Tianjin Zhongxin Pharmaceutical Group Corp Ltd cash flow reinvestment rate. Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Cash Flow Reinvestment Rate of 0.19x as of September 2025, reinvesting CN¥21.06 Million (capex CN¥21.06 Million ) from operating cash flow of CN¥110.78 Million. Explore debt repayment capacity of Tianjin Zhongxin Pharmaceutical Group Co to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Cash flow reinvestment rate of Tianjin Zhongxin Pharmaceutical Group Corp Ltd from 2001 to 2024. Historical reinvestment intensity for Tianjin Zhongxin Pharmaceutical Group Corp Ltd across 22 annual periods. Explore 600329 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Cash Flow Reinvestment Rate by Year (2001–2024)
Tianjin Zhongxin Pharmaceutical Group Corp Ltd cash flow reinvestment rate by year from 2001 to 2024. Year-by-year capital reinvestment analysis for Tianjin Zhongxin Pharmaceutical Group Corp Ltd. For the full cash flow conversion analysis, see how efficiently does Tianjin Zhongxin Pharmaceutical Group Co generate cash.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.00x | CN¥925.65 Million | CN¥924.67 Million | CN¥117.81 Million | ▼ -2.9% |
| 2023 | 1.03x | CN¥709.84 Million | CN¥688.49 Million | CN¥140.93 Million | ▲ +481.0% |
| 2022 | 0.18x | CN¥120.18 Million | CN¥677.25 Million | CN¥107.90 Million | ▼ -69.2% |
| 2021 | 0.58x | CN¥491.87 Million | CN¥852.40 Million | CN¥156.95 Million | ▲ +68.3% |
| 2020 | 0.34x | CN¥230.21 Million | CN¥671.42 Million | CN¥189.16 Million | ▼ -44.1% |
| 2019 | 0.61x | CN¥303.67 Million | CN¥495.49 Million | CN¥205.61 Million | ▼ -62.9% |
| 2018 | 1.65x | CN¥578.87 Million | CN¥350.14 Million | CN¥175.81 Million | ▲ +239.1% |
| 2016 | 0.49x | CN¥204.73 Million | CN¥419.90 Million | CN¥116.20 Million | ▼ -61.6% |
| 2015 | 1.27x | CN¥457.26 Million | CN¥360.58 Million | CN¥92.64 Million | ▲ +418.5% |
| 2014 | 0.24x | CN¥70.15 Million | CN¥286.85 Million | CN¥70.15 Million | ▼ -27.9% |
| 2013 | 0.34x | CN¥72.42 Million | CN¥213.44 Million | CN¥72.42 Million | ▼ -82.9% |
| 2012 | 1.98x | CN¥41.18 Million | CN¥20.81 Million | CN¥41.18 Million | ▲ +699.8% |
| 2011 | 0.25x | CN¥43.02 Million | CN¥173.88 Million | CN¥43.02 Million | ▼ -50.0% |
| 2010 | 0.49x | CN¥68.79 Million | CN¥139.04 Million | CN¥68.79 Million | ▼ -52.4% |
| 2009 | 1.04x | CN¥86.74 Million | CN¥83.41 Million | CN¥86.74 Million | ▲ +322.2% |
| 2008 | 0.25x | CN¥38.36 Million | CN¥155.77 Million | CN¥38.36 Million | ▼ -90.8% |
| 2007 | 2.67x | CN¥53.74 Million | CN¥20.13 Million | CN¥53.74 Million | ▲ +366.7% |
| 2005 | 0.57x | CN¥149.80 Million | CN¥261.91 Million | CN¥149.80 Million | ▼ -97.6% |
| 2004 | 24.04x | CN¥252.31 Million | CN¥10.50 Million | CN¥252.31 Million | ▲ +212.4% |
| 2003 | 7.70x | CN¥589.20 Million | CN¥76.57 Million | CN¥589.20 Million | ▲ +700.3% |
| 2002 | 0.96x | CN¥180.40 Million | CN¥187.60 Million | CN¥180.40 Million | ▲ +13.2% |
| 2001 | 0.85x | CN¥133.95 Million | CN¥157.73 Million | CN¥133.95 Million | — |